top of page

I3LUNG
INTEGRATIVE SCIENCE, INTELLIGENT DATA PLATFORM FOR INDIVIDUALIZED LUNG CANCER CARE WITH IMMUNOTHERAPY
CLINICAL TRIAL DETAILS
I3LUNG IS A EUROPEAN PROJECT FUNDED UNDER THE FRAMEWORK OF THE H2020 CALL "ENSURING ACCESS TO INNOVATIVE, SUSTAINABLE AND HIGH-QUALITY HEALTH CARE". THE PROJECT AIMS TO DEVELOP A MEDICAL DEVICE TO PREDICT IMMUNOTHERAPY EFFICACY FOR NSCLC PATIENTS THROUGH THE INTEGRATION OF MULTISOURCE DATA (REAL WORLD AND MULTI-OMICS DATA) FROM A RETROSPECTIVE AND A PROSPECTIVE PHASE. THE FINAL OBJECTIVE IS THE ESTABLISHMENT OF A WORLDWIDE DATA SHARING AND ELABORATION PLATFORM (DSEP) AND AN INDIVIDUALIZED PATIENT DECISION AID SYSTEM (iPDAS) TO SUPPORT CLINICIANS IN TREATMENT SELECTION.
TUMOR TYPE
PHASE
N
SITES
COUNTRY
STATUS
PRESS RELEASE
SCIENTIFIC IMPACT
WCLC 2025 paper: https://www.jto.org/article/S1556-0864(25)01291-2/abstract | WCLC 2025 paper: https://www.jto.org/article/S1556-0864(25)01109-8/abstract | WCLC 2025 paper: https://www.sciencedirect.com/science/article/abs/pii/S1556086425016491 | ASCO 2025 paper: https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.1568 | ESMO 2024 poster: https://www.medsir.org/_files/ugd/39f166_b7c7c829c7214ba5a6a99c72b5bf7390.pdf | ESMO 2024 lay language summary: https://www.medsir.org/_files/ugd/39f166_be56d70b2d9a40f897320e7fa6c43b84.pdf | Clinical Cancer Research 2023: https://www.clinical-lung-cancer.com/article/S1525-7304(23)00039-6/fulltext
BLOG ARTICLES RELATED
PHERGAIN SITES
Dr. Cortes and Dr. Llombart PHERain interview
Beyond Chemotherapy
Dr. Vanes Quiroga
Dr. Sofia Braga
Dr. Silvi AntolÃn
Dr. Escrivá de RomanÃ
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page

